The definition of obesity may be changing, potentially affecting how many people are considered obese. A new framework for clinical obesity treatment is being discussed, which could impact the use of weight loss medications, including GLP-1 drugs. The updated criteria may lead to a significant increase in the number of people who meet the criteria for obesity, although the exact implications are still being explored.